Other
Payments for Repurchase of Common Stock
Roivant Sciences Payments for Repurchase of Common Stock decreased by 29.5% to $208.29M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 67.9%, from $648.39M to $208.29M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2025Aug 11, 2025
How to read this metric
Higher spending indicates a commitment to returning capital to shareholders or offsetting dilution from stock-based compensation.
Detailed definition
The cash outflow associated with the company's repurchase of its own common shares from the open market. This is a prima...
Peer comparison
Standard capital return metric for mature public companies.
Metric ID:
other_payments_for_repurchase_of_common_stockHistorical Data
13 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $648.39M | $106.05M | $243.35M | $295.45M | $208.29M |
| QoQ Change | — | — | — | — | — | — | — | — | — | -83.6% | +129.5% | +21.4% | -29.5% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -67.9% |
Range$0.00 – $648.39M
Avg YoY Growth-67.9%
Median YoY Growth-67.9%
Payments for Repurchase of Common Stock at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's payments for repurchase of common stock?
- Roivant Sciences (ROIV) reported payments for repurchase of common stock of $208.29M in Q2 2025.
- How has Roivant Sciences's payments for repurchase of common stock changed year-over-year?
- Roivant Sciences's payments for repurchase of common stock decreased by 67.9% year-over-year, from $648.39M to $208.29M.
- What does payments for repurchase of common stock mean?
- Cash spent by the company to buy back its own common stock.